Oklahoma governor signs country’s most restrictive abortion ban into law

Oklahoma governor signs country’s most restrictive abortion ban into law


Oklahoma Governor Kevin Stitt speaks in Washington, DC. Stitt on Wednesday signed a bill that bans nearly all abortions after “fertilization,” making it the most restrictive abortion law in the country.

Alex Wong | Getty Images News | Getty Images

Oklahoma Gov. Kevin Stitt on Wednesday signed a bill that bans nearly all abortions after “fertilization,” making it the most restrictive abortion law in the country.

The state law, which goes into effect immediately, allows an abortion only when the life of a pregnant woman is at risk or when a pregnancy is the result of rape or incest that has been reported to law enforcement.

It also resembles a Texas law that lets people file civil suits against anyone who engages in aiding or abetting the procedure.

“I promised Oklahomans that as governor I would sign every piece of pro-life legislation that came across my desk and I am proud to keep that promise today,” Stitt, a Republican who is seeking a second term as governor, said in a statement. “From the moment life begins at conception is when we have a responsibility as human beings to do everything we can to protect that baby’s life and the life of the mother.”

The Center for Reproductive Rights and Planned Parenthood said Wednesday they would sue Oklahoma over the new law. 

Stitt previously signed into law a measure prohibiting abortions once cardiac activity can be detected, at about six weeks. The ban led the state’s four abortion clinics to refuse patients, NBC News reported this month.

Last month, Stitt signed a bill that makes it a felony to perform an abortion. The measure is set to go into effect this year.

Stitt signed the latest bill just weeks after a leaked draft majority opinion written by Justice Samuel Alito indicated that the Supreme Court is poised to overturn Roe v. Wade. A decision could come in late June or early July.

“We are seeing the beginning of a domino effect that will spread across the entire South and Midwest if Roe falls,” Nancy Northup, the president and CEO of the Center for Reproductive Rights, said in a statement Wednesday.

“Banning abortion after six weeks was not extreme enough for Oklahoma lawmakers. The goal of the anti-abortion movement is to ensure no one can access abortion at any point for any reason,” she said. “Right now, patients in Oklahoma are being thrown into a state of chaos and fear. That chaos will only intensify as surrounding states cut off access as well.”





Source

2026 is the year of obesity pills. Here’s how they could reshape the GLP-1 market
Health

2026 is the year of obesity pills. Here’s how they could reshape the GLP-1 market

The booming GLP-1 space was built on weekly injections. In 2026, new obesity pills will push the market into its next chapter. Patients are already getting their hands on the first GLP-1 pill for obesity from Danish drugmaker Novo Nordisk — a once-daily drug that shares the same brand name as its popular injection Wegovy. […]

Read More
Healthy Returns: What to expect from pharma at the JPM conference
Health

Healthy Returns: What to expect from pharma at the JPM conference

Heidi Overton, Novo Nordisk CEO Maziar Mike Doustdar, Eli Lilly CEO David A. Ricks, and U.S. Secretary of Commerce Howard Lutnick listen while U.S. President Donald Trump announces a deal with Eli Lilly and Novo Nordisk on to reduce the prices of GLP-1 weight‑loss drugs during an event in the Oval Office at the White […]

Read More
A little-known biotech stock has become a prime takeover target after surging nearly 1,700% last year
Health

A little-known biotech stock has become a prime takeover target after surging nearly 1,700% last year

Europe’s best-performing blue-chip stock in 2025 is widely expected to be bought by a larger peer, in a deal analysts say could be worth as much as $23 billion. Abivax, the French clinical-stage biotech company developing a treatment for ulcerative colitis and Crohn’s disease, saw shares rocket 1,681% last year, far outpacing the Stoxx 600 […]

Read More